Outlook Therapeutics (OTLK) Inventory Average (2025 - 2026)
Outlook Therapeutics (OTLK) posted quarterly Inventory Average of $3.4 million for Q1 2026, up 1.32% year-over-year from $3.4 million in Q1 2025, and little changed quarter-over-quarter from $3.4 million in Q4 2025.
Outlook Therapeutics (OTLK) Inventory Average (2025 - 2026) Analysis & Trends
Outlook Therapeutics (OTLK) has reported Inventory Average for 2 consecutive years, with $3.4 million the latest figure, recorded in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn | 90.57 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | 196.36 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 137.65 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | - |
| 10 | Outlook Therapeutics | 95.21 Mn | 83.97 Mn | -8,265.00 | 4.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.40 Mn |
| Dec 31, 2025 | 3.40 Mn |
| Sep 30, 2025 | 3.73 Mn |
| Jun 30, 2025 | 3.87 Mn |
| Mar 31, 2025 | 3.36 Mn |